GUGGENHEIM CAPITAL LLC - CLOVIS ONCOLOGY INC ownership

CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 194 filers reported holding CLOVIS ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is 0.87 and the average weighting 0.1%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of CLOVIS ONCOLOGY INC
ValueSharesWeighting
Q3 2019$570,000
-54.8%
145,108
+71.1%
0.01%
-50.0%
Q2 2019$1,261,000
-27.7%
84,830
+20.7%
0.01%
-28.6%
Q1 2019$1,745,000
+22.0%
70,297
-11.7%
0.01%
+16.7%
Q4 2018$1,430,000
-36.1%
79,620
+4.4%
0.01%
-20.0%
Q3 2018$2,239,000
-23.9%
76,231
+17.9%
0.02%
-25.0%
Q2 2018$2,941,000
+1.5%
64,635
+17.8%
0.02%
+185.7%
Q1 2018$2,897,000
-19.0%
54,855
+4.3%
0.01%
-12.5%
Q4 2017$3,575,000
-36.0%
52,593
-22.5%
0.01%
-38.5%
Q3 2017$5,589,000
+8.5%
67,842
+23.3%
0.01%
-7.1%
Q2 2017$5,149,000
+58.6%
55,002
+7.8%
0.01%
+55.6%
Q1 2017$3,247,000
+15.0%
50,999
-19.8%
0.01%
+12.5%
Q4 2016$2,824,000
+41.3%
63,568
-38.9%
0.01%
+33.3%
Q1 2016$1,999,000
-51.2%
104,121
-11.1%
0.01%
-50.0%
Q4 2015$4,099,000
-51.5%
117,108
+27.5%
0.01%
-53.8%
Q3 2015$8,448,000
-8.0%
91,867
-12.1%
0.03%
+13.0%
Q2 2015$9,181,000
+26.4%
104,476
+6.7%
0.02%
+35.3%
Q1 2015$7,266,000
+36.6%
97,891
+3.0%
0.02%
+30.8%
Q4 2014$5,320,000
+37.7%
95,001
+11.5%
0.01%
+44.4%
Q3 2014$3,864,000
+13.1%
85,187
+3.3%
0.01%0.0%
Q2 2014$3,416,000
-33.3%
82,501
+11.6%
0.01%
-40.0%
Q1 2014$5,121,000
+19.6%
73,932
+4.1%
0.02%
+15.4%
Q4 2013$4,280,000
+15.4%
71,022
+16.4%
0.01%0.0%
Q3 2013$3,710,00061,0400.01%
Other shareholders
CLOVIS ONCOLOGY INC shareholders Q1 2019
NameSharesValueWeighting ↓
Versant Venture Management, LLC 814,833$60,485,054,00053.20%
Palo Alto Investors LP 2,121,857$157,505,0007.79%
NEA Management Company, LLC 2,279,781$169,228,0007.65%
EcoR1 Capital, LLC 243,048$18,041,0006.01%
Redmile Group, LLC 900,879$66,872,0006.00%
Opaleye Management Inc. 140,000$10,392,0004.82%
PFM Health Sciences, LP 2,266,756$168,261,0004.64%
Partner Investment Management, L.P. 40,798$3,028,0004.56%
CLIFTON PARK CAPITAL MANAGEMENT, LLC 826,919$61,383,0003.74%
Opus Point Partners Management, LLC 55,988$4,156,0003.48%
View complete list of CLOVIS ONCOLOGY INC shareholders